NIH Technical Assistance Programs - Transition to Phase III
A cornerstone of the SBIR and STTR programs is helping companies move along the path of commercialization, with an emphasis on reducing technology risk and increasing the value proposition. NIH offers the Niche Assessment Program and Commercialization Assistance Program (CAP). These programs help SBIR/STTR awardees bring innovative solutions to health markets and into the hands of patients and caregivers alike. Technologies supported by the Niche Assessment Program and CAP include a range of drug, device, diagnostic or behavioral interventions that save and improve lives.
NIH SBIR/STTR Niche Assessment Program (NAP)
Provides active Phase I awardees with market research, and consumer and competition analysis. Topics include: new applications for the SBIR/STTR developed technology; needs and concerns of the end-user and new markets for possible entry.
NIH SBIR/STTR Commercialization Assistance Program (CAP)
Trains Phase II awardees on how to be market ready. Topics include: tailored market entry strategies; strategic partnerships; FDA regulatory requirements; financing strategies; investor pitches and intellectual property matters.